Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CTLA-4 gene polymorphisms associate with efficacy of postoperative radioiodine-131 for differentiated thyroid carcinoma.

Future oncology (London, England) - 1 May 2017

Chang De-Feng, Chen Xiao-Hong, Huang Jing, Sun Ya-Mei, Zhu Da-Yong, Xu Zhong-Qing

Abstract excerpt

AIM: To investigate the association of CTLA-4 polymorphisms with efficacy of postoperative radioiodine-131 (I-131) treatment for differentiated thyroid carcinoma (DTC). METHODS: A total of 324 DTC patients and 350 healthy individuals were enrolled in our study. Patients received I-131 remnant ablation following surgical resection. Based on the treatment efficacy, patients were divided into the effective (n = 183)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to CTLA-4 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Iodine Radioisotopes

Share to Kaplan-Meier Estimate

Share to Neoplasm Grading

Share to Recurrence

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 28326838
DOI: 10.2217/fon-2016-0399

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

CTLA-4 gene polymorphisms associate with efficacy of postoperative radioiodine-131 for differentiated thyroid carcinoma.PMID 28326838Read ↗

Vitamin D receptor polymorphisms associate with the efficacy and toxicity of radioiodine-131 therapy in patients with differentiated thyroid cancer.Semantic proximity Read ↗

Association between Thyroid Cancer and CTLA-4 Gene Polymorphisms.Semantic proximity Read ↗

Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.Semantic proximity Read ↗

Clinical outcome and influencing factors of differentiated thyroid cancer with biochemical incomplete response.Semantic proximity Read ↗

Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population.Semantic proximity Read ↗

hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.Semantic proximity Read ↗

Clinical Outcome and Prognosis of Differentiated Thyroid Carcinoma with Distant MetastasisSemantic proximity Read ↗

The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).Semantic proximity Read ↗

CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.Semantic proximity Read ↗

125I seeds implantation for lymph nodes metastasisfrom radioactive iodine-refractory differentiated thyroid carcinoma: A short-term efficacy and dosimetry studySemantic proximity Read ↗

Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.